3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
3
Sarcoma
1
Other hematologic neoplasm
1
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
2
Burkitt Lymphoma
2
Blast Crisis
2
Sezary Syndrome
1
Sarcoma, Myeloid
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Intraocular Lymphoma
1
Immunoblastic Lymphadenopathy
1
Dendritic Cell Sarcoma, Interdigitating
1
Cardiotoxicity
1
Interventions
Doxorubicin
2
hydrocortisone hemisuccinate
1
Vincristine
1
Razoxane
1
Radiotherapy
1
Prednisone
1
Methotrexate
1
Mercaptopurine
1
Medical History Taking
1
Leucovorin
1
Laser-Doppler Flowmetry
1
Hydrocortisone
1
Exercise
1
Electrocardiography
1
Echocardiography, Stress
1
Dexrazoxane
1
Cytarabine
1
Blood Cell Count
1
Asparaginase
1
Anthropometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Razoxane
×
Other hematologic neoplasm
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled